Literature DB >> 3821932

Sodium-dependence of the potency of inhibitors of the neuronal noradrenaline carrier in the rat vas deferens.

C J Zeitner, K H Graefe.   

Abstract

Vasa deferentia obtained from reserpine-pretreated rats were incubated (monoamine oxidase and catechol-O-methyltransferase inhibited) in media containing various concentrations of 3H-(-)noradrenaline and Na+ and initial rates of the neuronal uptake of 3H-noradrenaline measured both in the absence and presence of uptake inhibitors after 1 min of incubation. When rates of uptake were determined at various 3H-noradrenaline (1.0-12.2 mumol/l) and two fixed Na+ concentrations (25 and 140 mmol/l), the inhibition of uptake produced by (+)amphetamine, (-)metaraminol, desipramine, nomifensine and cocaine was competitive with respect to 3H-noradrenaline at both Na+ concentrations. While the Ki for (+)amphetamine, (-)metaraminol desipramine and nomifensine increased when the Na+ concentration was lowered, that for cocaine decreased. When the Na+ concentration was varied (10-140 mmol/l) and the 3H-noradrenaline concentration held constant (1.2 mumol/l), (+)amphetamine, (-)metaraminol, nomifensine and desipramine acted as mixed-type inhibitors with respect to Na+, and the inhibition of uptake produced by these drugs was the more pronounced, the higher the Na+ concentration. On the other hand, cocaine was competitive with Na+ and the inhibition produced by this drug was the more pronounced, the lower the Na+ concentration. It is concluded that the inhibitors of neuronal uptake tested here act in dependence on the external Na+ concentration. Desipramine and nomifensine resemble alternative amine substrates in being more potent at high than at low Na+ concentrations. On the other hand, cocaine is more potent at low than at high Na+ concentrations.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3821932     DOI: 10.1007/bf00569377

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  24 in total

1.  Statistical estimations in enzyme kinetics.

Authors:  G N WILKINSON
Journal:  Biochem J       Date:  1961-08       Impact factor: 3.857

2.  Effect of nomifensine (HOE 984), a new antidepressant, on uptake of noradrenaline and serotonin and on release of noradrenaline in rat brain synaptosomes.

Authors:  U Schacht; W Heptner
Journal:  Biochem Pharmacol       Date:  1974-12-15       Impact factor: 5.858

3.  The mode of sodium dependency of the adrenergic neuron amide carrier. Evidence for a second, sodium-dependent, optically specific and reserpine-sensitive system.

Authors:  M F Sugrue; P A Shore
Journal:  J Pharmacol Exp Ther       Date:  1969-12       Impact factor: 4.030

4.  Studies in vitro of amine uptake mechanisms in heart.

Authors:  A Giachetti; P A Shore
Journal:  Biochem Pharmacol       Date:  1966-05       Impact factor: 5.858

5.  Kinetic analysis of the interaction between noradrenaline and Na+ in neuronal uptake: kinetic evidence for CO-transport.

Authors:  S Sammet; K H Graefe
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1979-11       Impact factor: 3.000

6.  Role of sodium and potassium ions in storage of norepinephrine by sympathetic nerve endings.

Authors:  D F Bogdanski; B B Brodie
Journal:  Life Sci       Date:  1966-09       Impact factor: 5.037

7.  Solubilization and characterization of the 3H-desipramine binding site of rat phaeochromocytoma cells (PC12-cells).

Authors:  E Schömig; H Bönisch
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1986-12       Impact factor: 3.000

8.  Mechanism of efflux of noradrenaline from adrenergic nerves in rabbit atria.

Authors:  D M Paton
Journal:  Br J Pharmacol       Date:  1973-12       Impact factor: 8.739

9.  Effects of phenoxybenzamine on the uptake and metabolism of noradrenaline in the rat heart and vas deferens.

Authors:  L L Iversen; S Z Langer
Journal:  Br J Pharmacol       Date:  1969-11       Impact factor: 8.739

10.  Nomifensine and its derivatives as possible tools for studying amine uptake.

Authors:  J Tuomisto
Journal:  Eur J Pharmacol       Date:  1977-03-21       Impact factor: 4.432

View more
  8 in total

1.  Choline+: a substrate of the neuronal noradrenaline carrier in the rat vas deferens.

Authors:  A L Ungell; H Bönisch; K H Graefe
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1986-11       Impact factor: 3.000

2.  Release of vesicular noradrenaline in the rat tail artery induced by cocaine.

Authors:  V Palatý
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1988-11       Impact factor: 3.000

3.  Nerve impulse-induced release of endogenous noradrenaline and adrenaline from the perfused cod spleen.

Authors:  F Ehrenström; A L Ungell
Journal:  J Comp Physiol B       Date:  1990       Impact factor: 2.200

4.  Chloride-dependence of the potency of inhibitors of the neuronal noradrenaline carrier in the rat vas deferens.

Authors:  A L Ungell; H Oberleithner; K H Graefe
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1989 Jan-Feb       Impact factor: 3.000

5.  Vascular uptake of catecholamines in perfused lungs of the rat occurs by the same process as Uptake1 in noradrenergic neurones.

Authors:  L J Bryan-Lluka; N N Westwood; S R O'Donnell
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1992-03       Impact factor: 3.000

6.  The cocaine-insensitive component of non-exocytotic efflux of noradrenaline from adrenergic axons in the isolated rat tail artery.

Authors:  V Palatý
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1992-01       Impact factor: 3.000

7.  Failure of K+ to affect the potency of inhibitors of the neuronal noradrenaline carrier in the rat vas deferens.

Authors:  A L Ungell; K H Graefe
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1987-03       Impact factor: 3.000

8.  Early intraneuronal mobilization and deamination of noradrenaline during global ischemia in the isolated perfused rat heart.

Authors:  L Carlsson; K H Graefe; U Trendelenburg
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1987-11       Impact factor: 3.000

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.